Buy, Sell, or Hold Walgreen?

Today, Austin discusses the potential for pharmaceutical giant Walgreen (NYS: WAG) . The company's dividend and wide-ranging store basis give it a promising base network, but it still faces an uphill battle. Competitor CVS uses its own PBM, and the Express Scripts fallout continues to plague Walgreen. The recent Boots purchase will make it even harder for the company to shore up domestic issues, and it will struggle to grow unless a company like Rite Aid goes under and surrenders market share. Austin remains bearish on Walgreen and rates it as a definite sell.

If you're interested in some of these dividends on your quest for high-yielding stocks, The Motley Fool has compiled a special free report outlining our nine top dependable dividend-paying stocks. It's called "Secure Your Future With 9 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.

The article Buy, Sell, or Hold Walgreen? originally appeared on

Austin Smith has no positions in the stocks mentioned above. The Motley Fool owns shares of Express Scripts. Motley Fool newsletter services recommend Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.